LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Response to: "Comments on Somatostatin as Inflow Modulator in Liver-Transplant Recipients With Severe Portal Hypertension: A Randomized Trial" by Hakeem et al.

Photo by cdc from unsplash

6. Hessheimer A, Maza LM, Shwely AA, et al. Somatostatin and the ‘‘Small-For-Size’’ liver. Int J Mol Sci. 2019;20. E2512. 7. Lautt WW. Regulatory processes interacting to maintain hepatic blood… Click to show full abstract

6. Hessheimer A, Maza LM, Shwely AA, et al. Somatostatin and the ‘‘Small-For-Size’’ liver. Int J Mol Sci. 2019;20. E2512. 7. Lautt WW. Regulatory processes interacting to maintain hepatic blood flow constancy: vascular compliance, hepatic arterial buffer response, hepatorenal reflex, liver regeneration, escape from vasoconstriction. Hepatol Res. 2007;37: 891–903. 8. Emond J, Goodrich NP, Pomposelli MD. Hepatic hemodynamics and portal flow modulation: the A2ALL experience. Transplantation. 2017;101: 2375–2384. 9. Rammohan A, Govil S, Rela M. Portosystemic shunts for ‘‘Small for Size Syndrome’’ following liver transplantation: a Philosopher’s Stone? World J Surg. 2017;41:341–342. 10. Reddy MS, Kaliamoorthy I, Rajakumar A, et al. Double-blind randomized controlled trial of the routine perioperative use of terlipressin in adult living donor liver transplantation. Liver Transpl. 2017;23:1007–1014.

Keywords: response comments; response; somatostatin inflow; comments somatostatin; liver; trial

Journal Title: Annals of Surgery
Year Published: 2019

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.